Changes in infectious disease mortality in children during the past three decades

Pediatric Infectious Disease Journal

Volumn 32, Issue 9, 2013, Pages

  Lantto, Marjo ^a   Renko, Marjo ^a   Uhari, Matti ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Childhood mortality; Finland; Infection mortality; Neonatal mortality

Indexed keywords

CHICKENPOX VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CHICKENPOX; CHILDHOOD MORTALITY; FEMALE; HUMAN; INFANT; INFECTION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; STATISTICS; VACCINATION;

ADOLESCENT; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; FINLAND; HUMANS; INFANT; INFANT MORTALITY; MALE; SURVIVAL ANALYSIS; VACCINATION;

EID: 85047688808     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182930694     Document Type: Article

References (35)

1. Lantto M, Renko M, Uhari M. Trends in childhood mortality from 1969 to 2004 in Finland. Acta Paediatr. 2008;97:1024-1029.
2. Eskola J, Takala A, Kayhty H, et al. Experience in Finland with Haemophilus influenzae type b vaccines. Vaccine. 1991;9(suppl):S14-16; discussion S25.
3. Liu L, Johnson HL, Cousens S, et al.; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151-2161.
4. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
5. WHO Europe. The European health report 2005 (World Health Organization regional office for Europe web site). Available at: http://www.euro.who.int/ ehr2005. Accessed April 14, 2008.
6. Bailar JC. Significance factors for true ratio of Poisson variable to its expectation. Biometrics. 1964;20:639-664.
7. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: twoyear cycles with alternating prevalence of groups A and B. J Infect Dis. 1991;163:464-469.
8. National Institute for Health and Welfare. Infectious diseases in Finland 2007 (National Institute for Health and Welfare web site). Available at: http://www.julkari.fl/bitstream/handle/10024/78129/2008b09.pdf?sequence=l. Accessed February 16, 2013.
9. National Institute for Health and Welfare. Lahes kaikki suomalaislapset saavat rokotusohjelman mukaiset rokotteet (National Institute for Health and Welfare web site). Available at: www.thl.n7fl-FI/web/fi/tiedote?id=22315. Accessed February 23, 2013.
10. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med. 1994;331:1397-1402.
11. Dore GJ, Li Y, Plant AJ, et al. Trends in infectious disease mortality in Australia, 1979-1994. Med J Aust. 1998;168:601-604.
12. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA. 1996;275:189-193.
13. Wilson D, Bhopal R. Impact of infection on mortality and hospitalization in the North East of England. J Public Health Med. 1998;20:386-395.
14. World Health Organization. WHO Mortality Database: Tables (World Health Organization web site). Available at: http://apps.who.int/whosis/database/mort/ table2.cfm. Accessed June 6, 2009.
15. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110:145-160.
16. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185:147-152.
17. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-2567.
18. Harper SA, Fukuda K, Uyeki TM, et al.; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6):1-40.
19. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-231.
20. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30:784-789.
21. Salo H, Kilpi T, Sintonen H, et al. Cost-effectiveness of influenza vaccination of healthy children. Vaccine. 2006;24:4934-4941.
22. World Health Organization. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec. 1999;74:177-183.
23. Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
24. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr. 2002;161:188-195.
25. Klemets P, Lyytikainen O, Ruutu P, et al. Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis. 2008;40:621-628.
26. Whitney CG, Farley MM, Hadler J, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
27. Peltola H, Salo E, Saxen H. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. BMJ. 2005;330:18-19.
28. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
29. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
30. Marin M, Zhang JX, Seward JF Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128:214-220.
31. Christensen KK. Infection as a predominant cause of perinatal mortality. Obstet Gynecol. 1982;59:499-508.
32. Vesikari T, Isolauri E, Tuppurainen N, et al. Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset. Acta Paediatr Scand. 1989;78:44-50.
33. Embleton N, Wariyar U, Hey E. Mortality from early onset group B streptococcal infection in the United Kingdom. Arch Dis Child Fetal Neonatal Ed. 1999;80:F139-F141.
34. Lyytikainen O, Nuorti JP, Halmesmaki E, et al. Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis. 2003;9:469-473.
35. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.